Skip to main content
ACHV logo

ACHV · Achieve Life Sciences, Inc.

Track ACHV — free
$8.49 +0.18 (+2.17%) At close · Sep 4
Market Cap
$873.64M
Shares
102.90M

Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.

Fails to Deliver History

Settlement Date Quantity Price Value
2026-08-14 271,345 $7.25 $1,967,251
2026-08-13 1,636 $6.69 $10,945
2026-08-12 618,442 $6.77 $4,186,852
2026-08-11 395,783 $6.67 $2,639,873
2026-08-10 37,601 $6.65 $250,047
2026-08-06 14,414 $6.66 $95,997
2026-08-05 2,183 $6.47 $14,124
2026-08-04 25,041 $6.32 $158,259
2026-08-03 66,723 $6.42 $428,362
2026-07-31 26,333 $6.30 $165,898
2026-07-30 38,913 $6.18 $240,482
2026-07-29 76,984 $6.18 $475,761
2026-07-28 21,054 $6.18 $130,114
2026-07-27 7,305 $6.10 $44,561
2026-07-24 7,347 $6.17 $45,331
2026-07-23 140 $6.31 $883
2026-07-22 15,264 $6.50 $99,216
2026-07-21 38,359 $6.24 $239,360
2026-07-20 79,175 $6.27 $496,427
2026-07-17 21,680 $5.96 $129,213
2026-07-16 16,508 $6.33 $104,496
2026-07-15 6,932 $6.31 $43,741
2026-07-14 67,610 $6.10 $412,421
2026-07-13 27,482 $6.11 $167,915
2026-07-10 38,277 $6.40 $244,973
2026-07-09 134,457 $6.21 $834,978
2026-07-08 42,056 $6.52 $274,205
2026-07-07 28,684 $6.45 $185,012
2026-07-02 16,995 $6.40 $108,768
2026-07-01 251,331 $6.53 $1,641,191
2026-06-30 478,406 $6.23 $2,980,469
2026-06-29 921,651 $6.02 $5,548,339
2026-06-26 515,892 $5.70 $2,940,584
2026-06-25 26,910 $5.30 $142,623
2026-06-24 162,619 $5.01 $814,721
2026-06-23 213,469 $5.10 $1,088,692
2026-06-22 435,669 $4.85 $2,112,995
2026-06-18 57 $5.36 $306
2026-06-17 12,286 $5.55 $68,187
2026-06-16 10,668 $5.60 $59,741
2026-06-15 58,747 $5.52 $324,283
2026-06-12 70,151 $5.52 $387,234
2026-06-11 7,292 $5.75 $41,929
2026-06-10 16,779 $5.60 $93,962
2026-06-09 304 $5.48 $1,666
2026-06-08 33,747 $5.13 $173,122
Showing 1–46 of 46 settlements
Key facts CIK 949858 CUSIP 004468500 13F (30d) 83 filings 83 filers Visit website Investor relations